id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2021-V-1303-0003,FDA,FDA-2021-V-1303,Variance Approval Letter from FDA CDRH to DTX Digital Theater Experts,Other,Approval for Variance (VRA),2021-12-30T05:00:00Z,2021,12,2021-12-30T05:00:00Z,,2021-12-30T15:41:38Z,,0,0,0900006484f013fb
FDA-2021-V-1303-0002,FDA,FDA-2021-V-1303,Acknowledgment Letter from FDA DMS to DTX Digital Theater Experts,Other,Acknowledgement Letter/Receipt,2021-12-10T05:00:00Z,2021,12,2021-12-10T05:00:00Z,,2021-12-10T14:45:11Z,,0,0,0900006484eb334a
FDA-2021-V-1303-0001,FDA,FDA-2021-V-1303,VARIANCE APPLICATION FROM DTX DIGITAL THEATER EXPERTS,Other,Application for Variance (VAR),2021-12-10T05:00:00Z,2021,12,2021-12-10T05:00:00Z,,2021-12-10T14:24:15Z,,0,0,0900006484eb31a0